Treatment of Heterozygous Familial Hypercholesterolemia in Children and Adolescents: An Unsolved Problem.

[1]  L. Pérez de Isla,et al.  Attainment of LDL Cholesterol Treatment Goals in Children and Adolescents With Familial Hypercholesterolemia. The SAFEHEART Follow-up Registry. , 2017, Revista espanola de cardiologia.

[2]  L. P. D. Isla,et al.  Consecución de objetivos terapéuticos de colesterol LDL en niños y adolescentes con hipercolesterolemia familiar. Registro longitudinal SAFEHEART , 2017 .

[3]  J. G. Doblas,et al.  Necesidades no cubiertas con el tratamiento hipolipemiante oral: documento de posición de la Sociedad Española de Cardiología , 2016 .

[4]  N. Plana,et al.  Homozygous Familial Hypercholesterolemia in Spain: Prevalence and Phenotype-Genotype Relationship. , 2016, Circulation. Cardiovascular genetics.

[5]  J. Kastelein,et al.  Statins in Familial Hypercholesterolemia: Consequences for Coronary Artery Disease and All-Cause Mortality. , 2016, Journal of the American College of Cardiology.

[6]  César Martín,et al.  The p.Leu167del Mutation in APOE Gene Causes Autosomal Dominant Hypercholesterolemia by Down-regulation of LDL Receptor Expression in Hepatocytes. , 2016, The Journal of clinical endocrinology and metabolism.

[7]  B. Ference.  Mendelian randomization studies: using naturally randomized genetic data to fill evidence gaps , 2015, Current opinion in lipidology.

[8]  J. Borén,et al.  Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment , 2015, European heart journal.

[9]  P. Iversen,et al.  Mortality Among Patients With Familial Hypercholesterolemia: A Registry‐Based Study in Norway, 1992–2010 , 2014, Journal of the American Heart Association.

[10]  J. Kastelein,et al.  Ten-year follow-up after initiation of statin therapy in children with familial hypercholesterolemia. , 2014, JAMA.

[11]  A. Tonkin.  Faculty Opinions recommendation of Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. , 2014 .

[12]  N. Plana,et al.  [Expert consensus on the detection and clinical management of familial hypercholesterolemia]. , 2013, Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis.

[13]  S. Daniels,et al.  Pediatric aspects of familial hypercholesterolemias: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. , 2011, Journal of clinical lipidology.

[14]  Jennifer G. Robinson,et al.  Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. , 2011, Journal of clinical lipidology.

[15]  F. Civeira,et al.  Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia. , 2004, Atherosclerosis.

[16]  Wei Chen,et al.  Childhood cardiovascular risk factors and carotid vascular changes in adulthood: the Bogalusa Heart Study. , 2003, JAMA.

[17]  J. Strong,et al.  Association of Coronary Heart Disease Risk Factors with microscopic qualities of coronary atherosclerosis in youth. , 2000, Circulation.